{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:23:21Z","timestamp":1785453801680,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.7759\/cureus.100545","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T08:10:39Z","timestamp":1767255039000},"source":"Crossref","is-referenced-by-count":1,"title":["Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting"],"prefix":"10.7759","author":[{"given":"Waqar","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadia","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahwish","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Gull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimen","family":"Gull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0599-1","article-title":"Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia","volume":"34","author":"Kotrova M","year":"2020","unstructured":"Kotrova M, Volland A, Kehden B, et al.. Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia. Leukemia. 2020, 34:1154-7. 10.1038\/s41375-019-0599-1","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"G\u00f6kbuget N","year":"2018","unstructured":"G\u00f6kbuget N, Dombret H, Bonifacio M, et al.. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood. 2018, 131:1522-31. 10.1182\/blood-2017-08-798322","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002419","article-title":"Assessment of minimal residual disease in childhood acute lymphoblastic leukemia: a multicenter study from Turkey","volume":"44","author":"T\u00fcfek\u00e7i \u00d6","year":"2022","unstructured":"T\u00fcfek\u00e7i \u00d6, Evim MS, G\u00fcne\u015f AM, et al.. Assessment of minimal residual disease in childhood acute lymphoblastic leukemia: a multicenter study from Turkey. J Pediatr Hematol Oncol. 2022, 44:e396-402. 10.1097\/MPH.0000000000002419","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0580","article-title":"Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis","volume":"3","author":"Berry DA","year":"2017","unstructured":"Berry DA, Zhou S, Higley H, et al.. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017, 3:e170580. 10.1001\/jamaoncol.2017.0580","journal-title":"JAMA Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2019.06.549","article-title":"A single institution's experience with cytogenetic and mrd outcomes in pediatric acute lymphoblastic leukemia","volume":"29","author":"Amjad A","year":"2019","unstructured":"Amjad A, Wali RM, Anjum S, Mansoor R. A single institution's experience with cytogenetic and mrd outcomes in pediatric acute lymphoblastic leukemia. J Coll Physicians Surg Pak. 2019, 29:549-52. 10.29271\/jcpsp.2019.06.549","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00923","article-title":"Day 15 and day 33 minimal residual disease assessment for acute lymphoblastic leukemia patients treated according to the BFM ALL IC 2009 protocol: single-center experience of 133 cases","volume":"10","author":"Radu LE","year":"2020","unstructured":"Radu LE, Colita A, Pasca S, et al.. Day 15 and day 33 minimal residual disease assessment for acute lymphoblastic leukemia patients treated according to the BFM ALL IC 2009 protocol: single-center experience of 133 cases. Front Oncol. 2020, 10:923. 10.3389\/fonc.2020.00923","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1813563","article-title":"Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome","volume":"13","author":"Lashkari HP","year":"2020","unstructured":"Lashkari HP, Faheem M, Hanaganahalli BS, et al.. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome. Expert Rev Hematol. 2020, 13:1143-51. 10.1080\/17474086.2020.1813563","journal-title":"Expert Rev Hematol"},{"key":"ref8","article-title":"Mortality analysis in children during induction therapy for acute lymphoblastic leukemia","volume":"6","author":"Khan MI","year":"2017","unstructured":"Khan MI, Naseem L, Manzoor R, Yasmeen N. Mortality analysis in children during induction therapy for acute lymphoblastic leukemia. JIMDC. 2017, 6:69-72.","journal-title":"JIMDC"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001408","article-title":"Early deaths in pediatric acute leukemia: a major challenge in developing countries","volume":"41","author":"Hafez HA","year":"2019","unstructured":"Hafez HA, Soliaman RM, Bilal D, Hashem M, Shalaby LM. Early deaths in pediatric acute leukemia: a major challenge in developing countries. J Pediatr Hematol Oncol. 2019, 41:261-6. 10.1097\/MPH.0000000000001408","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.ijc_355_21","article-title":"ALL induction outcome: real-world data from a pediatric oncology center in an LMIC setup with rural predominance","volume":"61","author":"Sampagar A","year":"2024","unstructured":"Sampagar A, Patil NG, Reddy NA, Dias M. ALL induction outcome: real-world data from a pediatric oncology center in an LMIC setup with rural predominance. Indian J Cancer. 2024, 61:215-23. 10.4103\/ijc.ijc_355_21","journal-title":"Indian J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2022.11.1430","article-title":"Induction chemotherapy response in childhood acute lymphoblastic leukaemia and its correlation with cytogenetic and molecular features","volume":"32","author":"Rana NA","year":"2022","unstructured":"Rana NA, Mahmood A, Robert HM, Zahir S, Ali I, Riaz S. Induction chemotherapy response in childhood acute lymphoblastic leukaemia and its correlation with cytogenetic and molecular features. J Coll Physicians Surg Pak. 2022, 32:1430-4. 10.29271\/jcpsp.2022.11.1430","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.36283\/pjmd11-2\/005","article-title":"Frequency of BCR-ABL gene translocation in B-ALL patients associated with clinicopathological parameters","volume":"16","author":"Qamar A","year":"2024","unstructured":"Qamar A, Imran MZ, Afzal N, Hussain S, Andleeb M, Shakeel N. Frequency of BCR-ABL gene translocation in B-ALL patients associated with clinicopathological parameters. Pak J Med Dent. 2024, 16:2025-3. 10.36283\/pjmd11-2\/005","journal-title":"Pak J Med Dent"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124052","article-title":"Outcomes in pediatric acute lymphoblastic leukemia-a single-center Romanian experience","volume":"9","author":"Alecsa MS","year":"2020","unstructured":"Alecsa MS, Moscalu M, Trandafir LM, Ivanov AV, Rusu C, Miron IC. Outcomes in pediatric acute lymphoblastic leukemia-a single-center Romanian experience. J Clin Med. 2020, 9:4052. 10.3390\/jcm9124052","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425713-implication-of-post-induction-minimal-residual-disease-in-the-management-of-pediatric-acute-lymphoblastic-leukemia-in-a-resource-limited-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T08:10:39Z","timestamp":1767255039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425713-implication-of-post-induction-minimal-residual-disease-in-the-management-of-pediatric-acute-lymphoblastic-leukemia-in-a-resource-limited-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.100545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}